Safety and Effectiveness of Endovascular Therapy for the Treatment of Peripheral Artery Disease in Patients with and without Diabetes Mellitus. (November 2022)

• Record Type: Journal Article
• Authors: Korosoglou, Grigorios; Giusca, Sorin; Langhoff, Ralf; Lichtenberg, Michael; Lawall, Holger; Schellong, Sebastian; Stausberg, Jürgen; Hoffmann, Ulrich; Enders, Dominic; Malyar, Nasser
• Is Part Of: Angiology. Volume 73:Number 10(2022)
• Page Start: 956
• Page End: 966
• Publication Date: 2022-11
• Subjects: peripheral artery disease -- RECcording COurses of vasculaR Diseases -- endovascular therapies -- outcomes -- quality management -- diabetes mellitus -- claudication -- chronic limb-threatening ischaemia; Blood-vessels -- Diseases -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; 616.13005
• DOI: 10.1177/00033197221075857
• Languages: English
• ISSNs: 0003-3197

Abstract

This study investigated the distribution of risk factors, lesion characteristics and endovascular revascularization (EVR) strategies in patients with peripheral arterial disease (PAD) with vs without diabetes mellitus (DM). Data were collected within the RECcording COurses of vasculaR Diseases (RECCORD) registry. Demographic data, lesion localization (iliac vs femoropopliteal vs below-the-knee (BTK)) and lesion complexity score (LCS) based on number of affected segments, and lesion length (< 10 vs 10–20 vs > 20 cm), EVR strategies and peri-procedural complications were analysed in 786 patients with and 1337 without diabetes mellitus. Patients with diabetes mellitus were older (71.6 ± 9.6 vs 69.4 ± 10.5 years, P < .001) and had higher LCS and more often BTK lesions ( P < .05 for all). Lesions were treated less frequently with stents (48.7 vs 59.6%, P < .001) in patients with diabetes mellitus, whereas a non-significant trend was noticed for higher DCB treatment rates (48.3 vs 44.4%, P = .07). Post-interventional ankle-brachial index (ABI) increase was similar (from .77 ± .28 to .92 ± .25 with diabetes mellitus and from .74 ± .21 to .90 ± .20 without diabetes mellitus, P < .001 for both). Peri-/post-procedural complications were low in both groups (4.6%). Patients with diabetes mellitus, who undergo endovascular revascularization are older, have more comorbidities and higher target lesion complexity. However, treatment success rates are similar and complication rates are low.